Ultragenyx Pharmaceutical Inc. Financial Ratios — RARE Stock

Profitability (USD)

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Return on Common Equity (%)	- -	- -	- -	- -	-40.67	-48.93	-70.48	-39.83	-63.79	-20.64	-43.72	-110.96	-193.34	-214.55	- -
Return on Assets (%)	- -	-32.52	-47.4	-46.43	-38.45	-44.7	-58.59	-32.65	-43.42	-12.89	-27.67	-46.12	-39.98	-38.01	-37.89
Return on Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Gross Margin (%)	- -	- -	- -	- -	- -	100	99.96	97.77	91.31	97.74	95.44	92.21	89.63	86.25	83.8
EBITDA Margin (%)	- -	- -	- -	- -	- -	-183,896.99	-12,370.48	-683.24	-400.75	-117.28	-104.86	-173.59	-125.12	-89.29	-74.29
Operating Margin (%)	- -	- -	- -	- -	- -	-186,471.43	-12,593.49	-721.18	-408.98	-121.8	-108.63	-178.6	-131.11	-95.71	-79.49
Incremental Operating Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Pretax Margin (%)	- -	- -	- -	- -	- -	-184,841.35	-12,187.52	-382.75	-385.14	-68.39	-128.91	-193.14	-140.32	-101.25	-84.84
Profit Margin (%)	- -	- -	- -	- -	- -	-184,867.67	-11,567.34	-383.75	-388.31	-68.84	-129.2	-194.71	-139.86	-101.61	-85.44
Net Income to Common Margin (%)	- -	- -	- -	- -	- -	-184,867.67	-11,567.34	-383.75	-388.31	-68.84	-129.2	-194.71	-139.86	-101.61	-85.44
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Dvd Payout Ratio (%)	8.26	16.5	30.26	0.72	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	- -	- -	- -	- -	-40.67	-48.93	-70.48	-39.83	-63.79	-20.64	-43.72	-110.96	-193.34	-214.55	- -

Credit (USD)

Credit Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Total Debt	- -	- -	- -	- -	- -	- -	- -	- -	37	48	42	32	43	40	36
ST Debt	- -	- -	- -	- -	- -	- -	- -	- -	7	9	11	12	13	10	12
LT Debt	- -	- -	- -	- -	- -	- -	- -	- -	30	39	31	20	31	30	24
Total Debt/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	-0.09	-0.15	-0.11	-0.05	-0.08	-0.08	-0.07
Net Debt/EBITDA	1.63	5.5	0.23	0.43	0.64	0.66	0.31	0.32	1.04	2.24	0.83	0.21	0.39	0.35	0.84
Total Debt/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	-0.09	-0.15	-0.11	-0.05	-0.08	-0.07	-0.07
Net Debt/EBIT	1.62	5.39	0.23	0.43	0.63	0.65	0.31	0.31	1.02	2.16	0.81	0.2	0.38	0.32	0.79
EBITDA to Interest Expense	-24.17	- -	- -	- -	- -	- -	- -	- -	-366.2	-9.55	-12.52	-14.66	-8.23	-7.94	-8.06
EBITDA-CapEx/Interest Expense	-26.2	- -	- -	- -	- -	- -	- -	- -	-388.08	-10.87	-15.01	-18.06	-8.94	-8.25	-8.4
EBIT to Interest Expense	-24.3	- -	- -	- -	- -	- -	- -	- -	-373.72	-9.92	-12.97	-15.09	-8.62	-8.51	-8.63
Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	1	33	29	43	66	63	62
Common Equity/Total Assets	-65.64	-30.63	-125.44	93.42	94.91	87.67	78.14	84.62	57.58	65.61	60.6	22.81	18.47	16.97	-5.22
Long-Term Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	4.55	3.4	3.35	5.62	11.1	11.45	- -
Long-Term Debt/Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	4.31	3.26	3.2	5.16	9.6	9.93	-64.86
Long-Term Debt/Total Assets (%)	- -	- -	- -	- -	- -	- -	- -	- -	2.62	2.23	2.03	1.28	2.05	2	1.57
Total Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	5.66	4.18	4.55	8.96	15.67	15.27	-49.32
Total Debt/Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	5.36	4.01	4.35	8.23	13.55	13.25	-97.3
Total Debt/Total Assets (%)	- -	- -	- -	- -	- -	- -	- -	- -	3.26	2.74	2.76	2.04	2.9	2.66	2.35
Net Debt to Equity	-100.02	-102.19	-14.82	-13.15	-17.62	-33.99	-26.21	-18.63	-66.32	-61.81	-33.34	-37.72	-77.55	-66.41	576.71
Net Debt/Capital (%)	532,250	4,658.92	-17.4	-15.14	-21.39	-51.5	-35.51	-22.89	-168.6	-145.89	-46.82	-52.94	-203.42	-135.94	91.92
EBITDA	-7	-16	-32	-56	-146	-245	-323	-352	-416	-318	-368	-631	-543	-500	-500
EBITDA-CapEx	-7	-17	-32	-58	-151	-255	-326	-356	-440	-362	-442	-777	-590	-520	-521
Operating Income (Loss)	-7	-16	-32	-57	-148	-248	-329	-371	-424	-330	-382	-649	-569	-536	-535

Liquidity (USD)

Liquidity Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Cash Ratio	10.66	27.04	9.01	14.98	15.65	6.31	3.3	6.15	7.31	6.34	4.08	2.86	2.06	1.77	1.77
Current Ratio	10.96	27.12	9.33	15.45	16.13	6.67	3.8	6.99	8.24	6.83	4.72	3.38	2.61	2.38	2.48
Quick Ratio	10.76	27.04	9.01	14.98	15.65	6.31	3.37	6.32	7.63	6.46	4.24	3.02	2.32	2.13	2.18
CFO/Avg Current Liab	- -	-5.97	-6.85	-4.84	-5.24	-3.65	-3.87	-3.99	-3.88	-0.9	-1.83	-1.72	-1.75	-1.33	-1.28
Common Equity/Total Assets	-65.64	-30.63	-125.44	93.42	94.91	87.67	78.14	84.62	57.58	65.61	60.6	22.81	18.47	16.97	-5.22
Long-Term Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	4.55	3.4	3.35	5.62	11.1	11.45	- -
Long-Term Debt/Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	4.31	3.26	3.2	5.16	9.6	9.93	-64.86
Long-Term Debt/Total Assets (%)	- -	- -	- -	- -	- -	- -	- -	- -	2.62	2.23	2.03	1.28	2.05	2	1.57
Total Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	5.66	4.18	4.55	8.96	15.67	15.27	-49.32
Total Debt/Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	5.36	4.01	4.35	8.23	13.55	13.25	-97.3
Total Debt/Total Assets (%)	- -	- -	- -	- -	- -	- -	- -	- -	3.26	2.74	2.76	2.04	2.9	2.66	2.35
CFO/Total Liabilities	-391.99	-314.49	-327.04	-342.76	-372.12	-241.52	-236.58	-262.6	-71.7	-21.85	-56.46	-31.89	-39.08	-33.36	-29.03
CFO/CapEx	-10.63	-11.46	-76.66	-20.77	-21.39	-15.8	-90.89	-71.29	-13.91	-3.01	-4.63	-2.6	-10.11	-20.7	-22.19
Altman's Z-Score	-1.74	0.11	-2.55	63.73	91.22	23.97	4.86	8.18	0.58	8.06	3.61	-2.04	-2.47	-2.94	-4.32

Working Capital (USD)

Working Capital Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Accounts Receivable Turnover	- -	- -	- -	- -	- -	- -	1.01	5.75	4.55	9.69	13.64	10.55	7.63	5.73	4.81
Days Sales Outstanding	- -	- -	- -	- -	- -	- -	361.37	63.48	80.21	37.67	26.76	34.6	47.87	63.68	75.93
Inventory Turnover	- -	- -	- -	- -	- -	- -	- -	0.29	0.97	0.5	1.09	1.32	1.48	1.95	2.25
Days Inventory Outstanding	- -	- -	- -	- -	- -	- -	138,152.5	1,245.65	377.05	732.32	333.8	277.08	246.31	187.17	162.41
Accounts Payable Turnover	- -	- -	- -	- -	- -	- -	0.11	0.7	1.07	0.59	1.28	1.29	1.22	2.17	3.31
Accounts Payable Turnover Days	- -	- -	- -	- -	- -	- -	3,430.9	518.1	340.21	616.88	285.87	283.75	298.51	168.16	110.13
Cash Conversion Cycle	- -	- -	- -	- -	- -	- -	135,082.96	791.04	117.05	153.11	74.69	27.93	-4.33	82.68	128.21
Inventory to Cash Days	- -	- -	- -	- -	- -	- -	-137,791.13	-1,182.17	-296.84	-694.66	-307.04	-242.48	-198.45	-123.49	-86.48
Inventories	- -	- -	- -	- -	- -	- -	1	7	12	13	16	27	34	45	52
Raw Materials	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Work In Process	- -	- -	- -	- -	- -	- -	1	5	8	7	11	17	19	22	27
Finished Goods	- -	- -	- -	- -	- -	- -	- -	2	3	6	6	9	15	23	25
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

Enterprise Value API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Market Capitalization	- -	- -	- -	1,401	4,362	2,900	2,048	2,211	2,470	9,250	5,831	3,252	3,936	3,891	2,219
- Cash & Cash Equivalents	11	86	7	24	94	161	100	113	434	714	308	133	214	174	421
+ Preferred Equity and Hybrid Capital	19	111	125	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	7	7
+ Total Debt	- -	- -	- -	- -	- -	- -	- -	- -	37	48	42	32	43	40	36
Enterprise Value	8	25	72	1,214	3,925	2,519	1,814	1,752	1,752	8,096	5,133	2,536	3,402	3,328	1,582
Total Capital	11	84	50	185	531	474	383	609	691	1,203	965	384	319	302	-37
Total Debt/Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	5.36	4.01	4.35	8.23	13.55	13.25	-97.3
Total Debt / EV	- -	- -	- -	- -	- -	- -	- -	- -	0.02	0.01	0.01	0.01	0.01	0.01	0.02
EV/Sales	- -	- -	- -	- -	- -	18,943.25	694.48	34.02	16.89	29.87	14.61	6.98	7.84	5.94	2.35
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Free Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Diluted Market Cap	- -	- -	- -	1,262	4,126	2,783	1,969	2,164	2,416	8,423	5,701	3,239	3,517	3,809	2,268
Diluted Enterprise Value	8	25	118	1,237	4,033	2,622	1,868	2,051	2,020	7,758	5,435	3,138	3,346	3,682	1,890
EV per Share	0.27	0.87	2.46	38.01	100.94	61.09	41.07	34.44	30.29	121.17	74.02	36.13	41.33	35.98	16.4
TTM Sales	- -	- -	- -	- -	- -	- -	3	51	104	271	351	363	434	560	673
TTM EBITDA	-7	-16	-32	-56	-146	-245	-323	-352	-416	-318	-368	-631	-543	-500	-500
TTM Operating Income	-7	-16	-32	-57	-148	-248	-329	-371	-424	-330	-382	-649	-569	-536	-535
TTM Cash Flow to Firm	-6	-13	-31	-45	-106	-161	-254	-291	-344	-99	-309	-337	-409	-351	-404
TTM Free Cash Flow to Firm	-5	-11	-31	-42	-101	-151	-251	-286	-319	-55	-236	-191	-362	-331	-383

Multiples (USD)

Valuation Multiples API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Price/Free Cash Flow	- -	- -	- -	-29.7	-40.85	-18.46	-7.84	-7.55	-7.54	-95.37	-21.46	-13.82	-8.22	-9.67	-5.1
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Enterprise Value	8	25	72	1,214	3,925	2,519	1,814	1,752	1,752	8,096	5,133	2,536	3,402	3,328	1,582
Low Price	- -	- -	- -	32.02	44.27	46.52	43.14	37.44	35.41	31.99	72.89	33.36	31.52	37.02	18.41
EV/Sales	- -	- -	- -	- -	- -	18,943.25	694.48	34.02	16.89	29.87	14.61	6.98	7.84	5.94	2.35
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings Average	- -	- -	- -	-20.83	-22.06	-10.66	-8.59	-15.83	-7.59	-26.15	-15.32	-5.47	-5.08	-7.58	-6.01
Price/Earnings High	- -	- -	- -	-31.05	-34.62	-17.72	-12.83	-22.92	-10.47	-58.59	-26.13	-8.71	-6.66	-9.61	-7.97
Price/Earnings Low	- -	- -	- -	-14.25	-11.18	-7.49	-6.06	-9.43	-4.97	-10.43	-10.88	-3.3	-3.82	-5.89	-3.16
Price/Book Value	- -	- -	- -	7.58	8.21	6.12	5.34	3.63	3.78	8.01	6.32	9.23	14.29	15.26	-27.74
Price/Book Value Average	- -	- -	- -	8.08	6.39	5.76	7.04	5.25	4.78	4.64	7.71	11.02	12.52	17.27	-42.23
Price/Book Value High	- -	- -	- -	12.05	10.03	9.58	10.52	7.6	6.59	10.4	13.15	17.55	16.43	21.9	-56.08
Price/Book Value Low	- -	- -	- -	5.53	3.24	4.05	4.97	3.13	3.13	1.85	5.48	6.64	9.42	13.43	-22.2
Price/Tangible Book Value	- -	- -	- -	7.58	8.21	6.12	10.37	5.08	5.14	9.45	7.8	21.98	60.8	117.9	-7.4
Price/Tangible Book Value Average	- -	- -	- -	8.08	6.39	5.76	13.67	7.34	6.5	5.47	9.52	26.26	53.28	133.48	-11.26
Price/Tangible Book Value High	- -	- -	- -	12.05	10.03	9.58	20.43	10.63	8.97	12.26	16.24	41.8	69.91	169.19	-14.95
Price/Tangible Book Value Low	- -	- -	- -	5.53	3.24	4.05	9.65	4.37	4.26	2.18	6.76	15.82	40.08	103.75	-5.92
Price/Sales	- -	- -	- -	- -	- -	20,927.48	753.82	42.03	23.3	31.08	16.22	8.92	8.1	6.8	3.37
Price/Sales Average	- -	- -	- -	- -	- -	19,708.45	993.48	60.74	29.47	18	19.8	10.65	7.1	7.7	5.13
Price/Sales High	- -	- -	- -	- -	- -	32,758.91	1,484.64	87.94	40.64	40.33	33.76	16.96	9.32	9.76	6.81
Price/Sales Low	- -	- -	- -	- -	- -	13,846.49	701.16	36.19	19.32	7.18	14.06	6.42	5.34	5.99	2.7
Price/Cash Flow	- -	- -	- -	-28.27	-38.94	-17.29	-7.76	-7.45	-7	-63.7	-16.83	-8.51	-7.4	-9.2	-4.87
Price/Cash Flow Average	- -	- -	- -	-30.15	-30.31	-16.28	-10.22	-10.76	-8.85	-36.9	-20.54	-10.17	-6.49	-10.42	-7.41
Price/Cash Flow High	- -	- -	- -	-44.95	-47.57	-27.07	-15.28	-15.59	-12.2	-82.67	-35.03	-16.19	-8.51	-13.2	-9.84
Price/Cash Flow Low	- -	- -	- -	-20.63	-15.37	-11.44	-7.21	-6.41	-5.8	-14.72	-14.59	-6.13	-4.88	-8.1	-3.9
Price/Free Cash Flow Average	- -	- -	- -	-31.68	-31.8	-17.38	-10.34	-10.92	-9.53	-55.24	-26.19	-16.52	-7.2	-10.94	-7.76
Price/Free Cash Flow High	- -	- -	- -	-47.23	-49.9	-28.89	-15.45	-15.81	-13.15	-123.77	-44.67	-26.29	-9.45	-13.87	-10.3
Price/Free Cash Flow Low	- -	- -	- -	-21.67	-16.12	-12.21	-7.3	-6.5	-6.25	-22.04	-18.61	-9.95	-5.42	-8.51	-4.08
EV/Sales Average	- -	- -	- -	- -	- -	19,320.14	995.12	59.86	26.3	17.31	19.49	10.42	7.55	7.64	4.46
EV/Sales High	- -	- -	- -	- -	- -	32,915.64	1,506.11	87.66	37.72	41.83	33.78	16.75	10.04	9.74	6.1
EV/Sales Low	- -	- -	- -	- -	- -	13,213.35	691	34.78	15.92	5.43	13.63	6.17	5.59	5.89	2.08
EV/EBITDA Average	-1.22	-1.61	-3.69	-26.21	-22.56	-10.51	-8.04	-8.76	-6.56	-14.76	-18.59	-6	-6.04	-8.56	-6
EV/EBITDA High	-1.22	-1.61	-3.69	-39.29	-35.77	-17.9	-12.18	-12.83	-9.41	-35.67	-32.21	-9.65	-8.02	-10.91	-8.22
EV/EBITDA Low	-1.22	-1.61	-3.69	-17.8	-11.12	-7.19	-5.59	-5.09	-3.97	-4.63	-13	-3.55	-4.46	-6.59	-2.8
EV/EBIT Average	-1.21	-1.58	-3.64	-25.89	-22.35	-10.36	-7.9	-8.3	-6.43	-14.21	-17.95	-5.83	-5.76	-7.98	-5.61
EV/EBIT High	-1.21	-1.58	-3.64	-38.82	-35.44	-17.65	-11.96	-12.15	-9.22	-34.35	-31.09	-9.38	-7.65	-10.18	-7.68
EV/EBIT Low	-1.21	-1.58	-3.64	-17.58	-11.02	-7.09	-5.49	-4.82	-3.89	-4.46	-12.55	-3.45	-4.26	-6.15	-2.61
Last Price	- -	- -	- -	43.88	112.18	70.31	46.38	43.48	42.71	138.43	84.09	46.33	47.82	42.07	23
High Price	- -	- -	- -	69.77	137.05	110.06	91.34	90.98	74.5	179.65	175	88.12	54.98	60.37	46.5
Enterprise Value Average	8	25	118	1,470	3,302	2,570	2,599	3,083	2,728	4,692	6,851	3,785	3,279	4,278	3,001
Enterprise Value High	8	25	118	2,204	5,235	4,378	3,934	4,514	3,912	11,338	11,870	6,084	4,355	5,456	4,108
Enterprise Value Low	8	25	118	998	1,628	1,757	1,805	1,791	1,651	1,472	4,789	2,240	2,424	3,297	1,398

Shares Outstanding	29	29	29	32	39	41	44	51	58	67	69	70	82	92	96
Diluted Weighted Avg Shares	23	23	29	29	37	40	42	50	57	61	68	70	74	91	99
Basic Weighted Avg Shares	23	23	29	29	37	40	42	50	57	61	68	70	74	91	99
Revenue per Share	- -	- -	- -	- -	- -	- -	0.06	1.03	1.83	4.45	5.18	5.2	5.9	6.19	6.83
EBITDA per Share	-0.28	-0.68	-1.1	-1.95	-3.98	-6.18	-7.61	-7.07	-7.35	-5.22	-5.44	-9.02	-7.38	-5.52	-5.07
Operating Income per Share	-0.28	-0.69	-1.11	-1.97	-4.02	-6.26	-7.75	-7.46	-7.5	-5.43	-5.63	-9.28	-7.74	-5.92	-5.43
Basic EPS, GAAP	-0.32	-0.85	-1.73	-2.25	-3.96	-6.21	-7.12	-3.97	-7.12	-3.07	-6.7	-10.12	-8.25	-6.28	-5.83
Basic EPS from Cont Ops	-0.3	-0.71	-1.21	-2.08	-3.96	-6.21	-7.12	-3.97	-7.12	-3.07	-6.7	-10.12	-8.25	-6.28	-5.83
Diluted EPS, GAAP	-0.32	-0.85	-1.73	-2.25	-3.96	-6.21	-7.12	-3.97	-7.12	-3.07	-6.7	-10.12	-8.25	-6.28	-5.83
Diluted EPS from Cont Ops	-0.3	-0.71	-1.21	-2.08	-3.96	-6.21	-7.12	-3.97	-7.12	-3.07	-6.7	-10.12	-8.25	-6.28	-5.83
Dividend per Share	- -	- -	- -	0.15	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	-0.25	-0.54	-1.07	-1.55	-2.88	-4.07	-5.98	-5.84	-6.1	-2.17	-5	-5.44	-6.46	-4.57	-4.73
Free Cash Flow per Basic Share	-0.28	-0.59	-1.09	-1.63	-3.02	-4.32	-6.05	-5.92	-6.54	-2.89	-6.07	-7.53	-7.1	-4.79	-4.94
Cash & Equivalents per Share	0.37	2.97	1.84	5.87	11.24	9.22	5.31	9.04	13.06	17.98	10.67	10.65	7.01	6.6	7.05
Book Value per Share	-0.27	-0.93	-2.57	5.79	13.66	11.49	8.68	11.97	11.3	17.28	13.3	5.02	3.35	2.76	-0.83
Tangible Book Value per Share	-0.27	-0.93	-2.57	5.79	13.66	11.49	4.47	8.56	8.31	14.65	10.78	2.11	0.79	0.36	-3.11

Ultragenyx Pharmaceutical Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)